Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters
Traci L. Bricker, Tamarand L. Darling, Ahmed O. Hassan, et al.
Cell Reports (2021) Vol. 36, Iss. 3, pp. 109400-109400
Open Access | Times Cited: 150

Showing 1-25 of 150 citing articles:

Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Rita E. Chen, Xianwen Zhang, James Brett Case, et al.
Nature Medicine (2021) Vol. 27, Iss. 4, pp. 717-726
Open Access | Times Cited: 970
Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2
Sam Afkhami, Michael R. D’Agostino, Ali Zhang, et al.
Cell (2022) Vol. 185, Iss. 5, pp. 896-915.e19
Open Access | Times Cited: 264
Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
Samir Andrade Mendonça, Réka Lőrincz, Paul Boucher, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 243
Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
Tianyang Mao, Benjamin Israelow, Mario A. Peña-Hernández, et al.
Science (2022) Vol. 378, Iss. 6622
Open Access | Times Cited: 238
Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models
Neeltje van Doremalen, Jyothi N. Purushotham, Jonathan E. Schulz, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 607
Open Access | Times Cited: 225
The germinal centre B cell response to SARS-CoV-2
Brian J. Laidlaw, Ali H. Ellebedy
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 7-18
Open Access | Times Cited: 213
Intranasal COVID-19 vaccines: From bench to bed
Aqu Alu, Li Chen, Lei Hong, et al.
EBioMedicine (2022) Vol. 76, pp. 103841-103841
Open Access | Times Cited: 208
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
Dennis Lapuente, Jana Fuchs, Jonas Willar, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 183
Defining the risk of SARS-CoV-2 variants on immune protection
Marciela M. DeGrace, Elodie Ghedin, Matthew B. Frieman, et al.
Nature (2022) Vol. 605, Iss. 7911, pp. 640-652
Open Access | Times Cited: 152
COVID-19 induces CNS cytokine expression and loss of hippocampal neurogenesis
Allison Soung, Abigail Vanderheiden, Anna S. Nordvig, et al.
Brain (2022) Vol. 145, Iss. 12, pp. 4193-4201
Open Access | Times Cited: 128
A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques
Ahmed O. Hassan, Friederike Feldmann, Haiyan Zhao, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 4, pp. 100230-100230
Open Access | Times Cited: 122
An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
Ahmed O. Hassan, Swathi Shrihari, Matthew J. Gorman, et al.
Cell Reports (2021) Vol. 36, Iss. 4, pp. 109452-109452
Open Access | Times Cited: 119
A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2
Junyu Chen, Pui Wang, Lunzhi Yuan, et al.
Science Bulletin (2022) Vol. 67, Iss. 13, pp. 1372-1387
Open Access | Times Cited: 100
Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases
Shen Wang, Bo Liang, Weiqi Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 87
COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges
Kuldeep Dhama, Manish Dhawan, Ruchi Tiwari, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 75
Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters
Geraldine Nouailles, Julia M. Adler, Peter Pennitz, et al.
Nature Microbiology (2023) Vol. 8, Iss. 5, pp. 860-874
Open Access | Times Cited: 60
Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization
Tong Ye, Zhouguang Jiao, Xin Li, et al.
Nature (2023) Vol. 624, Iss. 7992, pp. 630-638
Closed Access | Times Cited: 51
COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development
Ramandeep Singh, Alisha Kang, Xiang‐Qian Luo, et al.
The FASEB Journal (2021) Vol. 35, Iss. 3
Open Access | Times Cited: 95
Adenovirus vector-based vaccine for infectious diseases
Fuminori Sakurai, Masashi Tachibana, Hiroyuki Mizuguchi
Drug Metabolism and Pharmacokinetics (2021) Vol. 42, pp. 100432-100432
Open Access | Times Cited: 93
SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodies
Michael Diamond, Rita Chen, Xuping Xie, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 86
Status Report on COVID-19 Vaccines Development
Arun Kumar, William E. Dowling, Raúl Gómez Román, et al.
Current Infectious Disease Reports (2021) Vol. 23, Iss. 6
Open Access | Times Cited: 78
Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2
Xingyue An, Melisa Martinez-Paniagua, Ali Rezvan, et al.
iScience (2021) Vol. 24, Iss. 9, pp. 103037-103037
Open Access | Times Cited: 77
COVID-19 induces neuroinflammation and loss of hippocampal neurogenesis
Robyn S. Klein, Allison Soung, Cheick A. Sissoko, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 77
Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies
Liubov I. Kozlovskaya, Anastasia N. Piniaeva, G. M. Ignatyev, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 1790-1806
Open Access | Times Cited: 68
ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7
Robert J. Fischer, Neeltje van Doremalen, Danielle R. Adney, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 65
Page 1 - Next Page

Scroll to top